Clinical Trials for Moderate to Severe Plaque Psoriasis

Find clinical trials for moderate to severe plaque psoriasis. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis

NCT ID: NCT06425549

This clinical trial is studying a new treatment called bimekizumab to see how well it works compared to an existing treatment called ustekinumab for children and teenagers aged 6 to under 18 who ha...

Recruiting

Phase: PHASE3 Type: interventional Locations: Los Angeles, California, United States, Northridge, California, United States +49 more

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

NCT ID: NCT06888193

This clinical trial is studying how much of the medication bimekizumab appears in the breast milk of mothers who are being treated for conditions like moderate to severe plaque psoriasis, psoriatic...

Recruiting

Phase: PHASE1 Type: interventional Locations: Calgary, , Canada

A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis

NCT ID: NCT06506916

This clinical trial is studying the effects of a medication called bimekizumab on people with moderate to severe plaque psoriasis, a skin condition that causes red, scaly patches. The trial aims to...

Recruiting

Phase: PHASE3 Type: interventional Locations: Birmingham, Alabama, United States, Fountain Valley, California, United States +15 more

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

NCT ID: NCT06696417

This clinical trial is studying a treatment called vunakizumab for people with moderate to severe plaque psoriasis, a skin condition that causes red, scaly patches on the skin. The trial will take ...

Recruiting

Type: observational Locations: Shenyang, Liaoning, China

A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis

NCT ID: NCT06943950

This clinical trial is testing a new medication called SYHX1901, which comes in tablet form, to see how well it works for treating moderate to severe plaque psoriasis. Plaque psoriasis is a skin co...

Not yet recruiting

Phase: PHASE3 Type: interventional

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

NCT ID: NCT06875934

This clinical trial is looking at a new treatment called SHR-1139 for people with moderate to severe plaque psoriasis, which is a condition that causes red, scaly patches on the skin. The main goal...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Shanghai, Shanghai, China

Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis

NCT ID: NCT06779097

This clinical trial is studying a new treatment called Vunakizumab for people with moderate to severe plaque psoriasis, a skin condition that causes red, scaly patches. The trial will involve about...

Not yet recruiting

Phase: PHASE4 Type: interventional Locations: Beijing, Beijing, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions